Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates and working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 Middle East & Africa
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 ICE and IVUS industry 3600 synopsis
2.1.1 Business trends
2.1.2 Application trends
2.1.3 End-use trends
2.1.4 Regional trends
Chapter 3 ICE and IVUS Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2028 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing incidence of cardiac disorders
3.3.1.2 Increasing preference of minimally invasive cardiac surgery procedures
3.3.1.3 Technological advancements and introduction of innovative devices
3.3.2 Industry pitfalls and challenges
3.3.2.1 Lack of skilled healthcare professionals
3.3.2.2 High cost of ICE and IVUS devices
3.4 Growth potential analysis
3.4.1 By application
3.4.2 By end-use
3.5 COVID-19 impact analysis
3.6 Pricing analysis
3.7 Adoption of ICE and IVUS
3.8 Porter’s analysis
3.9 Competitive landscape
3.10 PESTEL analysis
Chapter 4 ICE and IVUS Market, By Application
4.1 Key segment trends
4.2 Electrophysiology procedures
4.2.1 Market size, by region, 2017 - 2028 (USD Million)
4.3 Left atrial appendage closure
4.3.1 Market size, by region, 2017 - 2028 (USD Million)
4.4 Septal defects
4.4.1 Market size, by region, 2017 - 2028 (USD Million)
4.5 Others
4.5.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 5 ICE and IVUS Market, By End-use
5.1 Key segment trends
5.2 Hospitals
5.2.1 Market size, by region, 2017 - 2028 (USD Million)
5.3 Catherization laboratories
5.3.1 Market size, by region, 2017 - 2028 (USD Million)
5.4 Others
5.4.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 6 ICE and IVUS Market, By Region
6.1 Key regional trends
6.2 North America
6.2.1 Market size, by country, 2017 - 2028 (USD Mn)
6.2.2 Market size, by application, 2017 - 2028 (USD Mn)
6.2.3 Market size, by end-use, 2017 - 2028 (USD Mn)
6.2.4 U.S.
6.2.4.1 Market size, by application, 2017 - 2028 (USD Mn)
6.2.4.2 Market size, by end-use, 2017 - 2028 (USD Mn)
6.2.5 Canada
6.2.5.1 Market size, by application, 2017 - 2028 (USD Mn)
6.2.5.2 Market size, by end-use, 2017 - 2028 (USD Mn)
6.3 Europe
6.3.1 Market size, by country, 2017 - 2028 (USD Mn)
6.3.2 Market size, by application, 2017 - 2028 (USD Mn)
6.3.3 Market size, by end-use, 2017 - 2028 (USD Mn)
6.3.4 Germany
6.3.4.1 Market size, by application, 2017 - 2028 (USD Mn)
6.3.4.2 Market size, by end-use, 2017 - 2028 (USD Mn)
6.3.5 UK
6.3.5.1 Market size, by application, 2017 - 2028 (USD Mn)
6.3.5.2 Market size, by end-use, 2017 - 2028 (USD Mn)
6.3.6 France
6.3.6.1 Market size, by application, 2017 - 2028 (USD Mn)
6.3.6.2 Market size, by end-use, 2017 - 2028 (USD Mn)
6.3.7 Italy
6.3.7.1 Market size, by application, 2017 - 2028 (USD Mn)
6.3.7.2 Market size, by end-use, 2017 - 2028 (USD Mn)
6.3.8 Spain
6.3.8.1 Market size, by application, 2017 - 2028 (USD Mn)
6.3.8.2 Market size, by end-use, 2017 - 2028 (USD Mn)
6.4 Asia Pacific
6.4.1 Market size, by country, 2017 - 2028 (USD Mn)
6.4.2 Market size, by application, 2017 - 2028 (USD Mn)
6.4.3 Market size, by end-use, 2017 - 2028 (USD Mn)
6.4.4 China
6.4.4.1 Market size, by application, 2017 - 2028 (USD Mn)
6.4.4.2 Market size, by end-use, 2017 - 2028 (USD Mn)
6.4.5 Japan
6.4.5.1 Market size, by application, 2017 - 2028 (USD Mn)
6.4.5.2 Market size, by end-use, 2017 - 2028 (USD Mn)
6.4.6 India
6.4.6.1 Market size, by application, 2017 - 2028 (USD Mn)
6.4.6.2 Market size, by end-use, 2017 - 2028 (USD Mn)
6.5 Latin America
6.5.1 Market size, by country, 2017 - 2028 (USD Mn)
6.5.2 Market size, by application, 2017 - 2028 (USD Mn)
6.5.3 Market size, by end-use, 2017 - 2028 (USD Mn)
6.5.4 Brazil
6.5.4.1 Market size, by application, 2017 - 2028 (USD Mn)
6.5.4.2 Market size, by end-use, 2017 - 2028 (USD Mn)
6.5.5 Mexico
6.5.5.1 Market size, by application, 2017 - 2028 (USD Mn)
6.5.5.2 Market size, by end-use, 2017 - 2028 (USD Mn)
6.6 MEA
6.6.1 Market size, by country, 2017 - 2028 (USD Mn)
6.6.2 Market size, by application, 2017 - 2028 (USD Mn)
6.6.3 Market size, by end-use, 2017 - 2028 (USD Mn)
6.6.4 South Africa
6.6.4.1 Market size, by application, 2017 - 2028 (USD Mn)
6.6.4.2 Market size, by end-use, 2017 - 2028 (USD Mn)
6.6.5 Saudi Arabia
6.6.5.1 Market size, by application, 2017 - 2028 (USD Mn)
6.6.5.2 Market size, by end-use, 2017 - 2028 (USD Mn)
Chapter 7 Company Profiles
7.1 Competitive dashboard
7.2 Abbott Laboratories
7.2.1 Business overview
7.2.2 Financial data
7.2.3 Product landscape
7.2.4 Strategic outlook
7.2.5 SWOT analysis
7.3 Boston Scientific Corporation
7.3.1 Business overview
7.3.2 Financial data
7.3.3 Product landscape
7.3.4 Strategic outlook
7.3.5 SWOT analysis
7.4 Johnson & Johnson (Biosense Webster Inc.)
7.4.1 Business overview
7.4.2 Financial data
7.4.3 Product landscape
7.4.4 Strategic outlook
7.4.5 SWOT analysis
7.5 NIPRO (Infraredx, Inc.)
7.5.1 Business overview
7.5.2 Financial data
7.5.3 Product landscape
7.5.4 Strategic outlook
7.5.5 SWOT analysis
7.6 Conavi Medical
7.6.1 Business overview
7.6.2 Financial data
7.6.3 Product landscape
7.6.4 Strategic outlook
7.6.5 SWOT analysis
7.7 Siemens Healthcare GmbH
7.7.1 Business overview
7.7.2 Financial data
7.7.3 Product landscape
7.7.4 Strategic outlook
7.7.5 SWOT analysis
7.8 Koninklijke Philips N.V.
7.8.1 Business overview
7.8.2 Financial data
7.8.3 Product landscape
7.8.4 Strategic outlook
7.8.5 SWOT analysis
